Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial

Abstract : Antitumor activity of molecular-targeted agents is guided by the presence of documented genomic alteration in specific histological subtypes. We aim to explore the feasibility, efficacy and therapeutic impact of molecular profiling in routine setting.
Document type :
Journal articles
Complete list of metadatas

https://hal.inria.fr/hal-02367110
Contributor : Marie-France Sagot <>
Submitted on : Sunday, November 17, 2019 - 11:43:26 AM
Last modification on : Friday, November 22, 2019 - 4:00:04 PM

Identifiers

Collections

Citation

Olivier Trédan, Q. Wang, Daniel Pissaloux, Pierre Cassier, Arnaud de la Fouchardière, et al.. Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial. Annals of Oncology, Oxford University Press (OUP), 2019, 30 (5), pp.757-765. ⟨10.1093/annonc/mdz080⟩. ⟨hal-02367110⟩

Share

Metrics

Record views

38